ReviewJournal of clinical and translational hepatology2026

The CYB5R3-mARC1 Redox Axis in Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanistic Basis and Therapeutic Prospects across the Steatosis-Cirrhosis-Hepatocellular Carcinoma Spectrum.

Soon Woo NamPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.